TY - JOUR
T1 - Effects of the WHO Labour Care Guide on cesarean section in India: a pragmatic, stepped-wedge, cluster-randomized pilot trial
AU - Vogel, Joshua P.
AU - Pujar, Yeshita
AU - Vernekar, Sunil S.
AU - Armari, Elizabeth
AU - Pingray, Veronica
AU - Althabe, Fernando
AU - Gibbons, Luz
AU - Berrueta, Mabel
AU - Somannavar, Manjunath
AU - Ciganda, Alvaro
AU - Rodriguez, Rocio
AU - Bendigeri, Savitri
AU - Kumar, Jayashree Ashok
AU - Patil, Shruti Bhavi
AU - Karinagannanavar, Aravind
AU - Anteen, Raveendra R.
AU - Mallappa Ramachandrappa, Pavithra
AU - Shetty, Shukla
AU - Bommanal, Latha
AU - Haralahalli Mallesh, Megha
AU - Gaddi, Suman S.
AU - Chikkagowdra, Shaila
AU - Raghavendra, Bellara
AU - Homer, Caroline S.E.
AU - Lavender, Tina
AU - Kushtagi, Pralhad
AU - Hofmeyr, G. Justus
AU - Derman, Richard
AU - Goudar, Shivaprasad
PY - 2024/1/30
Y1 - 2024/1/30
N2 - Cesarean section rates worldwide are rising, driven by medically unnecessary cesarean use. The new World Health Organization Labour Care Guide (LCG) aims to improve the quality of care for women during labor and childbirth. Using the LCG might reduce overuse of cesarean; however, its effects have not been evaluated in randomized trials. We conducted a stepped-wedge, cluster-randomized pilot trial in four hospitals in India to evaluate the implementation of an LCG strategy intervention, compared with routine care. We performed this trial to pilot the intervention and obtain preliminary effectiveness data, informing future research. Eligible clusters were four hospitals with >4,000 births annually and cesarean rates ≥30%. Eligible women were those giving birth at ≥20 weeks' gestation. One hospital transitioned to intervention every 2 months, according to a random sequence. The primary outcome was the cesarean rate among women in Robson Group 1 (that is, those who were nulliparous and gave birth to a singleton, term pregnancy in cephalic presentation and in spontaneous labor). A total of 26,331 participants gave birth. A 5.5% crude absolute reduction in the primary outcome was observed (45.2% versus 39.7%; relative risk 0.85, 95% confidence interval 0.54-1.33). Maternal process-of-care outcomes were not significantly different, though labor augmentation with oxytocin was 18.0% lower with the LCG strategy. No differences were observed for other health outcomes or women's birth experiences. These findings can guide future definitive effectiveness trials, particularly in settings where urgent reversal of rising cesarean section rates is needed. Clinical Trials Registry India number: CTRI/2021/01/030695
AB - Cesarean section rates worldwide are rising, driven by medically unnecessary cesarean use. The new World Health Organization Labour Care Guide (LCG) aims to improve the quality of care for women during labor and childbirth. Using the LCG might reduce overuse of cesarean; however, its effects have not been evaluated in randomized trials. We conducted a stepped-wedge, cluster-randomized pilot trial in four hospitals in India to evaluate the implementation of an LCG strategy intervention, compared with routine care. We performed this trial to pilot the intervention and obtain preliminary effectiveness data, informing future research. Eligible clusters were four hospitals with >4,000 births annually and cesarean rates ≥30%. Eligible women were those giving birth at ≥20 weeks' gestation. One hospital transitioned to intervention every 2 months, according to a random sequence. The primary outcome was the cesarean rate among women in Robson Group 1 (that is, those who were nulliparous and gave birth to a singleton, term pregnancy in cephalic presentation and in spontaneous labor). A total of 26,331 participants gave birth. A 5.5% crude absolute reduction in the primary outcome was observed (45.2% versus 39.7%; relative risk 0.85, 95% confidence interval 0.54-1.33). Maternal process-of-care outcomes were not significantly different, though labor augmentation with oxytocin was 18.0% lower with the LCG strategy. No differences were observed for other health outcomes or women's birth experiences. These findings can guide future definitive effectiveness trials, particularly in settings where urgent reversal of rising cesarean section rates is needed. Clinical Trials Registry India number: CTRI/2021/01/030695
U2 - 10.1038/s41591-023-02751-4
DO - 10.1038/s41591-023-02751-4
M3 - Article
SN - 1078-8956
VL - 30
SP - 463
EP - 469
JO - Nature Medicine
JF - Nature Medicine
IS - 2
ER -